Introduction
============

Congenital cataracts, characterized by opacification of all or part of the eye\'s crystalline lens within the first year of life, are a leading cause of visual impairment or blindness in children \[[@r1]\]. The prevalence of congenital cataracts is 1 to 6 per 10,000 live births \[[@r2]\]. Cataracts can be isolated or occur in association with a large number of metabolic diseases and genetic syndromes. Congenital cataracts are most frequently inherited as autosomal dominant traits, but can also be inherited in an autosomal recessive or X-linked fashion \[[@r3]\]. According to morphology, congenital cataracts can be classified into several subtypes: whole lens, nuclear, lamellar, cortical, polar, sutural, pulverulent, cerulean, coralliform, and other minor subtypes \[[@r4]\].

Approximately half of all cataract families have crystallin mutations, including crystalline, alpha A (*CRYAA*), crystallin, alpha B (*CRYAB*), crystallin, beta A1 (*CRYBA1/A3*), crystallin, beta A4 (*CRYBA4*), crystallin, beta B1 (*CRYBB1*), crystallin, beta B2 (*CRYBB2*), crystallin, gamma C (*CRYGC*), crystallin, gamma D (*CRYGD*), crystallin, gamma S (*CRYGS*). About one quarter have connexin mutations in gap junctional proteins, including gap junction protein, alpha 3, 46kDa (*GJA3*), and gap junction protein, alpha 8, 50kDa (*GJA8*), with the remainder divided among the genes for heat shock transcription factor-4 (*HSF4*), aquaporin-0 (*AQP0*, *MIP*), and beaded filament structural protein-2 (*BFSP2*) \[[@r5]\].

We applied a functional candidate approach testing the known cataract-causing genes in a Chinese family. A G→T splice mutation in *CRYBA1/A3* was identified to be responsible for cataracts in the family. This is the first report to relate this mutation site to Y-suture cataracts also involving opacities of the nucleus.

Methods
=======

Family data
-----------

A five-generation Chinese family from Shandong Province with a history of cataracts was recruited from Beijing Tongren Hospital, Capital Medical University, Beijing, China. The research was approved by the ethics committee of Capital Medical University. Informed consent was obtained from all participants of the family. The study protocol followed the principles of the Declaration of Helsinki.

Detailed family medical history was recorded by interviewing the family members. All participating members underwent ophthalmic examination, including visual acuity, slit-lamp examination, intraocular pressure measurement, ultrasonography, and fundus examination of the dilated pupil. Slit-lamp photography was performed to document the phenotype of the cataracts in the patients. One hundred unrelated subjects without cataracts were recruited from the Ophthalmology Clinic of Beijing Tongren Hospital as normal controls and were given complete ophthalmologic examinations. None of the controls exhibited eye diseases except mild myopia.

Genomic DNA preparation
-----------------------

About 2 ml of peripheral blood was collected from the family members who took part in the study. Genomic DNA was extracted from blood using the QIAamp Blood kit (Qiagen, Valencia, CA).

Mutation screening
------------------

We used the functional candidate gene analysis approach, including *CRYAA* (GenBank [NM_000394](http://www.ncbi.nlm.nih.gov/nuccore/NM_000394)), *CRYAB* (GenBank [NM_001885](http://www.ncbi.nlm.nih.gov/nuccore/NM_001885)), *CRYBA1* (GenBank [NM_005208](http://www.ncbi.nlm.nih.gov/nuccore/NM_005208)), *CRYBB1* (GenBank [NM_001887](http://www.ncbi.nlm.nih.gov/nuccore/NM_001887)), *CRYBB2* (GenBank [NM_000496](http://www.ncbi.nlm.nih.gov/nuccore/NM_000496)), *CRYGC* (GenBank [NM_020989](http://www.ncbi.nlm.nih.gov/nuccore/NM_020989)), *CRYGD* (GenBank [NM_006891](http://www.ncbi.nlm.nih.gov/nuccore/NM_006891)), *CRYGS* (GenBank [NM_017541](http://www.ncbi.nlm.nih.gov/nuccore/NM_017541)), *GJA3* (GenBank [NM_021954](http://www.ncbi.nlm.nih.gov/nuccore/NM_021954)), *GJA8* (GenBank [NM_005267](http://www.ncbi.nlm.nih.gov/nuccore/NM_005267)), *MIP* (GenBank [NM_012064.3](http://www.ncbi.nlm.nih.gov/nuccore/NM_012064.3)), *HSF4* (GenBank [NM_001040667.2](http://www.ncbi.nlm.nih.gov/nuccore/NM_001040667.2)), and *BFSP2* (GenBank [NM_003571](http://www.ncbi.nlm.nih.gov/nuccore/NM_003571)). Each exon and intron-exon junction of the genes were amplified by polymerase chain reaction (PCR) using previously published primer sequences ([Table 1](#t1){ref-type="table"}) \[[@r6]\]. Each reaction mix (25 μl) contained 20 ng of genomic DNA, 1× PCR buffer,1.5 mM MgCl~2~, 0.2 mM dNTPs, 0.5 μM each of forward and reverse primers and 2.5 U of Taq DNA polymerase (Qiagen). A PCR program was performed for DNA amplifying: 95 °C for 5 min; followed by 35 cycles at 95 °C for 30 s, 57 °C-63 °C for 30 s (annealing temperature depending on different primer); 72 °C for 30 s; and a final extension at 72 °C for 10 min. The PCR products of the proband and one unaffected member were sequenced using an ABI3730 Automated Sequencer (PE Biosystems, Foster City, CA). The sequencing results were analyzed using [Chromas 2.33](http://www.technelysium.com.au/chromas.html) and compared with the reference sequence in the [NCBI](http://www.ncbi.nlm.nih.gov/) database. Then we screened the mutation in *CRYBA1/A3* from the sample of the family members and 100 ethnically matched controls to confirm the mutation.

###### Primers used for PCR.

  **Name**     **Forward (5′-3′)**         **Reverse (5′-3′)**
  ------------ --------------------------- --------------------------
  CRYAA-1      AGCAGCCTTCTTCATGAGC         CAAGACCAGAGTCCATCG
  CRYAA-2      GGCAGGTGACCGAAGCATC         GAAGGCATGGTGCAGGTG
  CRYAA-3      GCAGCTTCTCTGGCATGG          GGGAAGCAAAGGAAGACAGA
  CRYAB-1      AACCCCTGACATCACCATTC        AAGGACTCTCCCGTCCTAGC
  CRYAB-2      CCATCCCATTCCCTTACCTT        GCCTCCAAAGCTGATAGCAC
  CRYAB-3      TCTCTCTGCCTCTTTCCTCA        CCTTGGAGCCCTCTAAATCA
  CRYBA1--1    GGCAGAGGGAGAGCAGAGTG        CACTAGGCAGGAGAACTGGG
  CRYBA1--2    AGTGAGCAGCAGAGCCAGAA        GGTCAGTCACTGCCTTATGG
  CRYBA1--3    AAGCACAGAGTCAGACTGAAGT      CCCCTGTCTGAAGGGACCTG
  CRYBA1--4    GTACAGCTCTACTGGGATTG        ACTGATGATAAATAGCATGAACG
  CRYBA1--5    GAATGATAGCCATAGCACTAG       TACCGATACGTATGAAATCTGA
  CRYBA1--6    CATCTCATACCATTGTGTTGAG      GCAAGGTCTCATGCTTGAGG
  CRYBB1--1    CCCTGGCTGGGGTTGTTGA         TGCCTATCTGCCTGTCTGTTTCTC
  CRYBB1--2    TAGCGGGGTAATGGAGGGTG        AGGATAAGAGTCTGGGGAGGTGG
  CRYBB1--3    CCTGCACTGCTGGCTTTTATTTA     TCTCCAGAGCCCAGAACCATG
  CRYBB1--4    CCAACTCCAAGGAAACAGGCATA     CCTCCCTACCCACCATCATCTC
  CRYBB1--5    TAGACAGCAGTGGTCCCTGGAGA     AGCACTGGGAGACTGTGGAAGG
  CRYBB1--6    CCTAGAAAAGGAAACCGAGGCC      AGCGAGGAAGTCACATCCCAGTA
  CRYBB2--1    GTTTGGGGCCAGAGGGGAGTGGT     TGGGCTGGGGAGGGACTTTCAGTA
  CRYBB2--2    CCTTCAGCATCCTTTGGGTTCTCT    GCAGTTCTAAAAGCTTCATCAGTC
  CRYBB2--3    GTAGCCAGGATTCTGCCATAGGAA    GTGCCCTCTGGAGCATTTCATAGT
  CRYBB2--4    GGCCCCCTCACCCATACTCA        CTTCCCTCCTGCCTCAACCTAATC
  CRYBB2--5    CTTACCCTTGGGAAGTGGCAATGG    TCAAAGACCCACAGCAGACAAGTT
  CRYGC-1      TGCATAAAATCCCCTTACCG        CCTCCCTGTAACCCACATTG
  CRYGC-2      TGGTTGGACAAATTCTGGAAG       CCCACCCCATTCACTTCTTA
  CRYGD-1      CAGCAGCCCTCCTGCTAT          GGGTCCTGACTTGAGGATGT
  CRYGD-2      GCTTTTCTTCTCTTTTTATTTCTGG   AAGAAAGACACAAGCAAATCAGT
  CRYGS-2      GAAACCATCAATAGCGTCTAAATG    TGAAAAGCGGGTAGGCTAAA
  CRYGS-3      AATTAAGCCACCCAGCTCCT        GGGAGTACACAGTCCCCAGA
  CRYGS-4      GACCTGCTGGTGATTTCCAT        CACTGTGGCGAGCACTGTAT
  GJA3--1      CGGTGTTCATGAGCATTTTC        CTCTTCAGCTGCTCCTCCTC
  GJA3--2      GAGGAGGAGCAGCTGAAGAG        AGCGGTGTGCGCATAGTAG
  GJA3--3      TCGGGTTCCCACCCTACTAT        TATCTGCTGGTGGGAAGTGC
  GJA8--1      CCGCGTTAGCAAAAACAGAT        CCTCCATGCGGACGTAGT
  GJA8--2      GCAGATCATCTTCGTCTCCA        GGCCACAGACAACATGAACA
  GJA8--3      CCACGGAGAAAACCATCTTC        GAGCGTAGGAAGGCAGTGTC
  GJA8--4      TCGAGGAGAAGATCAGCACA        GGCTGCTGGCTTTGCTTAG
  MIP-1        GTGAAGGGGTTAAGAGGC          GGAGTCAGGGCAATAGAG
  MIP-2,3      CGGGGAAGTCTTGAGGAG          CACGCAGAAGGAAAGCAG
  MIP-4        CCACTAAGG TGGCTGGAA         CTCATGCCCCAAAACTCA
  HSF4--1      CATCCCATCCAGCCAGCCTTTTC     GGGCATGGGTGTTCACTGACGT
  HSF4--2      CCTCGACCCATATCCCCGTAAG      GCAGGAGCAAGGCAGGCAGTC
  HSF4--3      GCGGGAATGAGCAAAGAGGAGG      GCCAAGGCAGGAGAGAGGAAGG
  HSF4--4      TCCCCAGCCTCGCCATTCT         CCCGGTGAAGGAGTTTCCAGAG
  HSF4--5      GCTGGGGCCTGAGGGAG           GGCTTCCATCTTCTCTTCCTTTT
  BFSP2 (1a)   AATGCACAAACCCAAATGGT        AGGCCCTGSSGACACT
  BFSP2 (1b)   GAGAGGCGAGTGGTAGTGGA        GGCCTCAGCCTACTCACAAC
  BFSP2 (2)    TGCAGACAGAGCATTTCCAC        GAGGGGTGTGAGCTGGATAA
  BFSP2 (3)    GCTGCAATTGCCTTCATTTT        GGGTAACCTGACCCAACTTCA
  BFSP2 (4)    TCTGTGAAGCCTGTGTCTGG        CCCGGCCTCAATTATTCTTT
  BFSP2 (5)    ACCCAGGAGGAGGAGGTTGT        GGGAATCCCCTGGAAACTAA
  BFSP2 (6)    GGGGAATAGTCCAGGCTACC        ATGGGTGCCTATGTGAGAGGG
  BFSP2 (7)    TTGTTCCAAAGGCCAGATTC        CACTCAAGGGAATCCTTCCA

Results
=======

Clinical evaluation
-------------------

Thirteen family members of a five-generation Chinese family with a history of cataracts participated in the study (six affected and seven unaffected individuals; [Figure 1](#f1){ref-type="fig"}). All patients in this family had bilateral cataracts. Most patients experienced decreased visual acuity at 3--4 years old, and then their visual acuity decreased gradually until surgery was required. The proband, who was a 3-year-old girl, experienced a decrease in vision at 1.5 years old and had been diagnosed with bilateral cataracts at age 3. Slit-lamp examination revealed opacification of Y- sutue cataracts with opacities involving nucleus. The girl's best corrected visual acuity was 0.3/0.3. Her clinical features were similar to those of her uncle (IV:6) with peripheral cortical opacity ([Figure 2](#f2){ref-type="fig"}). His best corrected visual acuity was 0.3 /0.4. The affected member IV:3, who was the father of the proband, had undergone cataract removal at age 8.

![A five-generation Chinese family with autosomal dominant cataract. The black symbols indicate individuals with a diagnosis of congenital cataracts by doctors. The arrow indicates the proband. The asterisks indicate family members who attend this study. Family members IV:2 and V:2 were only several months old and did not take part in the study. We do not know whether they are affected.](mv-v17-2065-f1){#f1}

![Slit lamp photographs of different individuals. Slit lamp photographs of individual V:1 (**A** and **B**). **A**: Y-suture opacities of the lens involving the nucleus. **B**: Slit lamp photograph of the eye after the lens was extracted. **C** and **D**: The photographs of individual IV:6 show Y-suture opacities of the lens involving the nucleus and peripheral cortex. The phenotypes of both are almost the same.](mv-v17-2065-f2){#f2}

Mutation analysis
-----------------

Through direct gene sequencing of the coding regions of the candidate genes, we identified an IVS3+1 G→T substitution in the donor splice site of intron 3 in *CRYBA1/A3* in all affected individuals ([Figure 3](#f3){ref-type="fig"}). However, we did not find this mutation in any unaffected family members or in the 100 unrelated controls. We did not find any other mutations in this family except for a few non-pathogenic single nucleotide polymorphisms (SNPs).

![Sequence analysis of *CRYBA1/A3* at exon 3. **A**: Sequence of affected (individual V:1). **B**: Sequence of unaffected individual (individual IV:5). In panel **A**, the mutation G→T was evident at the first base of intron 3, which was identified in all patients of the family, but was not found in the unaffected family members nor in the 100 unrelated control subjects.](mv-v17-2065-f3){#f3}

Discussion
==========

In this study we identified a splice site mutation of *CRYBA1/A3* in a five-generation Chinese family with Y-suture opacities of the lens involving embryonic and fetal nuclei.

Sutural cataracts affect the sutural regions of the nucleus, at which the ends of the lens fiber cells meet. Sutural cataracts may occur in isolation or be associated with opacities involving other lens regions. There is some correlation between the pattern of expression of the mutant gene and the morphology of the resulting cataract.

To date, seven genes have been identified to be associated with suture cataracts, including *BFSP2, CRYBA1/A3, CRYBBA, CRYBB2, GJA8, FTL, CRYGA.* Among these genes, almost all the mutations of *BFSP2* are associated with suture cataract phenotype. *CRYBA1/A3* has great correlation with suture cataracts ([Table 2](#t2){ref-type="table"}).

###### Summary of mutations responsible for suture cataract.

  **Gene**   **Position**   **Sequence change**   **Lens phenotype**                                                    **Reference**
  ---------- -------------- --------------------- --------------------------------------------------------------------- ---------------
  *CRYGA*    2q33-q35       Unknown               Sutural cataract                                                      \[[@r7]\]
  *FTL*      19q13.3        32 G\>A               Y-suture congenital cataract                                          \[[@r8]\]
  *GJA8*     1q21           235G\>C               Full moon with Y-suture cataract                                      \[[@r9]\]
  *GJA8*     1q21           262C\>A               Y-suture cataract                                                     \[[@r10]\]
  *BFSP2*    3q21.3-q27.2   697--699delGAA        Y-suture cataract                                                     \[[@r11]\]
  *BFSP2*    3q21.3-q27.2   697--699delGAA\*      Congenital nuclear and sutural cataract                               \[[@r12]\]
  *BFSP2*    3q21.3-q27.2   696--698delGAA        Progressive sutural congenital cataract                               \[[@r13]\]
  *BFSP2*    3q21.3-q27.2   696--698delGAA        Progressive congenital cataract with suture and cortex opacity        \[[@r14]\]
  *CRYBA1*   14q13-q21      IVS3+1G\>A            Sutural, nuclear, and peripheral cortical opacity                     \[[@r15]\]
  *CRYBA1*   4q13-q21       IVS3+1G\>C            Zonular and sutural cataract                                          \[[@r16]\]
  *CRYBA1*   4q13-q21                             Y-shaped sutural cataract                                             \[[@r17]\]
  *CRYBA1*   4q13-q21       IVS3+1 G\>A           Progressive childhood cataract with Y-suture opacity                  \[[@r18]\]
  *CRYBB2*   22q11.23       483C\>T               opacities with suture and cerulean                                    \[[@r19]\]
  *CRYBB1*   22q12.1        658G\>T               Ustlike cataract with the anterior and posterior Y-suture opacities   \[[@r20]\]

So far, in the *CRYBA1/A3* gene, three types of mutations have been associated with autosomal dominant cataracts. Our report of IVS3+1 G→T will be the fourth type of *CRYBA1/A3* mutation. The first one is the IVS3+1 G→A mutation. Regarding IVS3+1 G→A, in 1998 Kannabiran et al. \[[@r21]\] reported an Indian family with zonular cataracts with sutural opacities. In 2008, Devi et al. \[[@r22]\] reported another two Indian families with zonular lamellar cataracts. In 2004, Burdon et al. \[[@r15]\] reported an Australian family with Y-sutural cataracts. In 2010, Gu et al. \[[@r23]\] identified a Chinese family with posterior polar cataracts, which was the first time this mutation was found in the Chinese population. Also in 2010, Zhu et al. \[[@r18]\]reported a Chinese family with progressive childhood cataracts characterized by opacities in the fetal nucleus and peripheral cortex. The second type of mutation is IVS3+1 G→C. In 2000, Bateman et al. \[[@r16]\] reported a Brazilian family with varied clinical characteristics among the affected members. The affected individuals who were examined had pulverulent opacities in the embryonal nucleus and sutures and star-shaped, shieldlike, or radial opacities in the posterior embryonal nucleus. The third type of mutation is a 3-bp deletion at positions 276--281 in exon 4, which causes an in-frame deletion of a glycine residue at position 91 (ΔG91). In 2004, Qi et al. \[[@r24]\] identified a Chinese family with nuclear cataracts. In 2007, Lu et al. \[[@r25]\] reported two Chinese families with pulverulent congenital cataracts ([Table 3](#t3){ref-type="table"}).

###### Summary of mutations in *CRYBA1/A3* responsible for congenital cataract.

  **Exon**   **Nucleotide**                 **Amino acid**          **Phenotype**                                                  **Reference**
  ---------- ------------------------------ ----------------------- -------------------------------------------------------------- ---------------
  IVS3       IVS3+1G\>A                     Splice site mutation    Zonular cataract with sutural opacity                          \[[@r21]\]
  IVS3       IVS3+1G\>A                     Splice site mutation    Zonular lamellar cataract                                      \[[@r22]\]
  IVS3       IVS3+1G\>A                     Splice site mutation    Y-sutural,mild nucleus and cortical dot cataract               \[[@r15]\]
  IVS3       IVS3+1G\>A                     Splice site mutation    Posterior polar cataract                                       \[[@r23]\]
  IVS3       IVS3+1G\>A                     Splice site mutation    Progressive childhood nucleus and peripheral cortex cataract   \[[@r18]\]
  IVS3       IVS3+1G\>C                     Splice site mutation    Pulverulent, star-shaped, shieldlike and radial cataract       \[[@r16]\]
  EX4        278--280delGGA                 P.91Glydel              Nuclear cataract                                               \[[@r24]\]
  EX4        279--281delGGA276--278delGGA   P.91Glydel P.91Glydel   Pulverulent congenital cataracts                               \[[@r25]\]
  EX4        279--281delGGA                 P.91Glydel              Congenital nuclear cataract                                    \[[@r26]\]

*CRYBA1/A3* consists of six exons encoding two proteins (βA3-crystallin and βA1-crystallin) by using an alternative translation initiation site. βA1/A3-crystallin consists of seven protein regions: four homologous (Greek key) motifs, a connecting peptide, and NH2- and COOH-terminal extensions.

In the *CRYBA1/A3* gene, the first two exons encode the sequence of the N-terminal arm, and exons 3--6 encode the Greek key motifs 1--4 \[[@r27]\]. The G at position +1 of the 5′ (donor) splice site is highly conserved, and mutation of this base can be expected to disrupt the splice site \[[@r28]\]. In this study the mutation at IVS3+1 G→T can be expected to skip the donor splice junction, which may cause the wrong junction of the exons in *CRYBA1/A3.* This may result in premature termination of the polypeptide. In this condition, it would cause structural instability and disrupt the folding of the protein \[[@r21]\].

In conclusion, we have identified a new type IVS3+1 G→T mutation of the *CRYBA1/A3* gene associated with Y-sutural congenital cataracts in a Chinese family. This mutation supports the role of the *CRYBA1/A3* gene in human cataract formation and provides more evidence of genetic heterogeneity of congenital cataracts.
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